Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

PIN*POINT method available for licensing from NIH

March 27, 1998

Incyte licenses RNA amplification technology and related patent

March 27, 1998

FDA advisory committee recommends expanded labeling for CEPRATE SC System

March 26, 1998

Ribozyme, Parke-Davis collaboration confirmed

March 25, 1998

Progenitor, CAT establish gene-to-clinic collaboration

March 25, 1998

T7T7 increases efficacy of cancer gene therapy in preclinical studies

March 24, 1998

Progress made in Lilly/Emisphere protein delivery collaboration

March 20, 1998

LifeCell will be awarded U.S. patent for blood cell preservation technology

March 19, 1998

Morphogenesis awarded phase I SBIR grant

March 18, 1998

SangStat and Dyax enter license agreement

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...